MyFinsight
Home
Blog
About
Contact
Download
Download image
Net transfers from
former parent
$301,505K
Net cash provided by
financing activities
$301,505K
Net increase in cash
and cash...
$268,264K
Canceled cashflow
$33,241K
something is missing
$12,863K
Stock-based compensation
expense
$12,213K
Other current assets
-$1,208K
Lease liabilities
$890K
Non-cash operating lease
costs
$841K
Depreciation
$151K
Net cash used in
operating activities
-$31,143K
Net cash used in
investing activities
-$2,098K
Canceled cashflow
$28,166K
Net loss
-$16,633K
Accrued compensation
-$15,838K
Purchases of property and
equipment
$2,098K
Collaboration receivable
$15,000K
Deferred revenues
-$4,635K
Accounts payable
-$3,591K
Accrued liabilities
-$1,995K
Prepaid and other assets
$1,043K
Other long-term
liabilities
-$574K
Back
Back
Cash Flow
source: myfinsight.com
Avidity Biosciences, Inc. (RNA)
Avidity Biosciences, Inc. (RNA)